Is DNA destiny? A cure for cystic fibrosis

Clinics in Chest Medicine

Volumn 19, Issue 3, 1998, Pages 527-534

  Robinson, C B ^a  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPOSOME; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; CLINICAL TRIAL; CYSTIC FIBROSIS; GENE THERAPY; GENE TRANSFER; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031713164     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70098-8     Document Type: Article

References (42)

1. E.W. Alton D. Geddes Gene therapy for cystic fibrosis: Steady progress, should do well Eur Respir J 10 1997 257 259
2. E.W. Alton F. Middleton P. Caplen Noninvasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice Nat Genet 5 1993 135 142
3. D. Armentano J. Zabner C. Sacks Effect of the E4 region on the persistence of transgene expression from adenovirus vectors J Virol 71 1997 2408 2416
4. G. Bellon L. Michel-Calemard D. Thouvenot Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial Hum Gene Ther 8 1997 15 25
5. K. Berkner Development of adenovirus vectors for the expression of heterologous genes Biotechniques 6 1988 616 629
6. N. Caplen E. Alton P. Middleton Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis Nat Med 1 1995 39 46
7. R.G. Crystal A. Mastrangeli A. Sanders Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis Hum Gene Ther 6 1995 667 703
8. R.G. Crystal N.G. McElvaney M.A. Rosenfeld Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis Nat Genet 8 1994 42 71
9. J. Engelhardt J. Yankaskas S. Ernst Submucosal glands are the predominant site of CFTR expression in the human bronchus Nat Genet 2 1992 240 248
10. FitzSimmons, S. Cystic Fibrosis Foundation Patient Registry Annual Data Report 1996. Bethesda, MD, 1997.
11. T. Flotte S. Afione C. Conrad Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adenoassociated virus vector Proc Natl Acad Sci 90 1993 10613 10617
12. M. Goldman J.M. Wilson Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway J Virol 69 1995 5951 5958
13. M. Goldman G. Anderson E. Stolzenberg Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis Cell 88 1997 553 560
14. J.G. Hay N.G. McElvaney J. Herena Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector Hum Gene Ther 6 1995 1487 1496
15. M. Horwitz Adenoviridae and their replication B. Fields Virology 1990 Raven Press New York 1679 1721
16. M. Howard M.D. DuVall D.C. Devor Epitope tagging permits cell surface detection of functional CFTR Am J Physiol 269 1995 C1565 C1576
17. S. Hyde D. Gill C. Higgins Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy Nature 362 1993 250 255
18. L.G. Johnson S.E. Boyles J. Wilson Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells J Clin Invest 95 1995 1377 1382
19. M.R. Knowles K.W. Hohneker Z. Zhou A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis N Engl J Med 333 1995 823 831
20. M.R. Knowles A.M. Paradiso R. Boucher In vivo nasal potential difference: Techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis Hum Gene Ther 6 1995 445 455
21. M. Leigh J. Kylander J. Yankaskas Cell proliferation in bronchial epithelium and submucosal glands of cystic fibrosis patients Am J Respir Cell Mol Biol 12 1995 605 612
22. A. Mastrangeli B. Harvey J. Yao “Sero-switch” adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype Hum Gene Ther 7 1996 79 87
23. N. McElvaney R. Crystal IL-6 release and airway administration of human CFTR cDNA adenovirus vector Nat Med 1 1995 182 184
24. J.M. Pilewski J.D. Latoche S. Arcasoy Expression of integrin cell adhesion receptors during human airway epithelial repair in vivo Am J Physiol 273 1997 L256 L263
25. D.J. Porteous J.R. Dorin G. McLachlan Evidence for safety and efficacy of DOTAP cationic lipsome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis Gene Ther 4 1997 210 218
26. D. Rich L. Couture L. Cardoza Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis Hum Gene Ther 4 1993 461 476
27. J.R. Riordan J. Rommens B. Kerem Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA Science 245 1989 1066 1073
28. J. Rommens M. Iannuzzi B. Kerem Identification of the cystic fibrosis gene: chromosome walking and jumping Science 245 1989 1059 1065
29. M. Rosenfeld F.S. Collins Gene therapy for cystic fibrosis Chest 109 1996 241 252
30. R. Rubinstein U. McVeigh T. Flotte CFTR gene transduction in neonatal rabbits using an adeno-associated virus vector Gene Ther 4 1997 384 392
31. R. Samulski Adeno-associated virus: Integration at a specific chromosomal locus Curr Opin Genet Dev 3 1993 74 80
32. A. Scaria J. St George R. Gregory Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway Gene Ther 4 1997 611 617
33. K.W. Southern S.C. Hyde E.M. Fitzjohn Repeated nasal administration of liposome-mediated CFTR gene transfer reagents: The clinical and immunological consequences Pediatr Pulmonol Suppl 14 1997 A209
34. J. Smith S. Travis E. Greenberg Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 229 236
35. M. Stern F.M. Munkonge N.J. Caplen Quantitative fluorescence measurements of chloride secretion in native airway epithelium from CF and non-CF subjects Gene Ther 2 1995 766 774
36. S. Teramoto L. Johnson W. Huang Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells Hum Gene Ther 6 1995 1045 1053
37. J. Wagner M. Moran A. Messner Efficient and persistent gene transfer of AAV-CFTR in the maxillary sinus of CF patients with antrostomies [abstr] Pediatr Pulmonol Suppl 14 1997 A216
38. J.M. Wilson Gene therapy for cystic fibrosis: Challenges and future directions J Clin Invest 96 1995 2547 2554
39. Y. Yang Q. Li H. Ertl Cellular and humoral immune response to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses J Virol 69 1995 2004 2015
40. Y. Yang F. Nunes K. Berencsi Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proc Natl Acad Sci 91 1994 4407 4411
41. J. Zabner S.H. Cheng D. Meeker Comparison of DNA–lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo J Clin Invest 100 1997 1529 1537
42. J. Zabner L.A. Couture R.J. Gregory Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis Cell 75 1993 207 216